Sanofi (SNY)
Data as of September 4, 2026 · Drug Manufacturers - General
Stockbruh grade: Strong 4/5 metrics rated Sunny
What does Sanofi do?
Sanofi, a global leader in therapeutic solutions, headquartered in Paris, is all about improving your health and well-being. With a wide range of specialty care products, vaccines, and consumer healthcare options, they've got you covered from head to toe. From diabetes medicines to flu vaccines, they're committed to keeping you healthy and vibrant. They even have collaborations to develop a Covid-19 vaccine and advance immunology research.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛈️ Weak | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ☀️ Strong | Revenue & earnings trend |
| Earnings | ☀️ Strong | EPS vs analyst expectations |
| Cash & Debt | ☀️ Strong | Balance sheet strength |
| Price | $44.33 | Market Cap | — |
| Exchange | NASDAQ Global Select | | |
Plain-English Analysis
What's it worth?
Returns have been below average recently — worth reviewing valuation carefully before investing. Sign up free to see the full Stockbruh valuation breakdown.
How the business works
Sanofi, a global leader in therapeutic solutions, headquartered in Paris, is all about improving your health and well-being. With a wide range of specialty care products, vaccines, and consumer healthcare options, they've got you covered from head to toe. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Revenue and earnings are trending upward — Sanofi appears to be growing. Sign up free for the full growth analysis including year-over-year comparisons and R&D investment data.
What's ahead?
Recent earnings have been strong, meeting or beating analyst expectations. Sign up free for earnings history, EPS trends, and what analysts are forecasting next.